Clinical Trial

Different Dose Esketamine and Dexmedetomidine Combination for Supplemental Analgesia After Scoliosis Correction Surgery

Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
Scoliosis correction surgery is associated with severe pain. Patients after scoliosis correction surgery usually require high dose opioids and long duration analgesia, which may increase side effects and drug tolerance. In a recent trial, mini-dose esketamine and dexmedetomidine combination as a supplement to sufentanil significantly improved analgesia and subjective sleep quality after spinal correction surgery without increasing adverse events; however, the proportion of patients with moderate-to-severe pain remained high. The authors speculate that increasing esketamine dose in the combination may further improve analgesic effects.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-09-25; most recent amendment 2026-04-07.
Status change: Recruiting → Active, Not Recruiting 2026-04-07
Status change: Not Yet Recruiting → Recruiting 2025-07-29
Trial Details
NCT Number NCT06062550
Lead Sponsor Peking University First Hospital
Conditions Scoliosis Correction, Esketamine, Dexmedetomidine, Postoperative Analgesia, Chronic Postsurgical Pain
Enrollment 312 participants
Start Date 2023-10-24
Primary Completion 2025-10-23 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2026-04-13